http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9814205-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13fdcd619e15c320d642de7703fffa7 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-605 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001151 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate | 1997-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8033ef3518cc2192922b16af320e55a3 |
publicationDate | 1998-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-9814205-A1 |
titleOfInvention | Cancer therapy using an oncogene product and a foreign mhc molecule |
abstract | A cancer immunogen comprises foreign MHC molecules and additionally one or more oncognes (or constructs that will produce an antigenic region thereof) which can be used to immunise against tumours containing the same or similar oncogenes. Where pathogen-free allogeneic cells are used, it may not be necessary to kill the vaccine before it is administered. The efficacy of the vaccine may be enhanced if the cells also contain immunoenhancing molecules, tumour antigens, or third-party antigens. Cell vaccines containing oncongens can be standardised and used to treat (risk of) specific cancers where there are analogous oncongenes in the tumour or pre-cancerous cells. A panel of such cells covering different oncogenes may be used. The vaccines can be used to immunise prophylactically, in conjuction with other therapy, post-surgery or on their own. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7402306-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9186418-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7670611-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-763485-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0066153-A1 |
priorityDate | 1996-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.